Targeting HSP90 for cancer therapy

por Mahalingam, D, Swords, R, Carew, J S, Nawrocki, S T, Bhalla, K, Giles, F J
Publicado 2009

Isocitrate dehydrogenase mutations in myeloid malignancies

por Medeiros, B C, Fathi, A T, DiNardo, C D, Pollyea, D A, Chan, S M, Swords, R
Publicado 2017

Acute leukemia in adult Hispanic Americans: a large-population study

por Swords, R, Sznol, J, Elias, R, Watts, J, Zelent, A, Martin, E, Vargas, F, Bethel-Ellison, S, Kobetz, E
Publicado 2016

Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes

por Swords, R T, Watts, J, Erba, H P, Altman, J K, Maris, M, Anwer, F, Hua, Z, Stein, H, Faessel, H, Sedarati, F, Dezube, B J, Giles, F J, Medeiros, B C, DeAngelo, D J
Publicado 2017